Sign in
KRBP Stock Price, Chart, Stats & News
Kiromic BioPharma, Inc.
Save
Kiromic BioPharma, Inc. (KRBP) does not currently pay a dividend.
214,932
Market cap
–
Current P/E
–
Forward P/E
KRBP chart
Price history is unavailable
We don't have enough price data for KRBP to draw a chart yet.
About
Health care
Sector
Biotechnology
Industry
Kiromic BioPharma, Inc. is a biotechnology enterprise that harnesses artificial intelligence to advance allogeneic cell therapies. The company's core mission involves crafting multi-indication T-cell treatments, specifically engineered to combat solid tumors by leveraging the innate capabilities of Gamma Delta T cells. Its developmental pipeline includes ALEXIS-ISO-1, an allogeneic gamma delta CAR-T cell therapy targeting Isomesothelin, and ALEXIS-PRO-1, an allogeneic gamma delta chimeric T cell therapy designed to address PD-L1.
Similar securities
Based on sector and market capitalization
Report issue